Vanguard Capital Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,266
Closed -$211K 139
2019
Q2
$211K Buy
+1,266
New +$175K 0.26% 103
2018
Q4
Sell
-3,326
Closed -$633K 141
2018
Q3
$633K Sell
3,326
-780
-19% -$143K 0.72% 41
2018
Q2
$684K Hold
4,106
0.91% 39
2018
Q1
$680K Buy
+4,106
New +$689K 0.9% 38

Other funds holding AGN

Vanguard Capital Wealth Advisors's AGN Position: Q3 2019 in Review

Vanguard Capital Wealth Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,266 shares — an estimated $211K sold.

Vanguard Capital Wealth Advisors first reported a position in AGN in Q1 2018 and held it in 4 quarters. The position peaked at $684K in Q2 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Vanguard Capital Wealth Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 1,266 Allergan plc shares in Q3 2019, an estimated $211K.
  • Vanguard Capital Wealth Advisors first reported a position in Allergan plc in Q1 2018 and held it in 4 quarters.
  • Vanguard Capital Wealth Advisors's Allergan plc position peaked at $684K in Q2 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.